150 related articles for article (PubMed ID: 24870766)
1. Stathmin is a marker of progression and poor prognosis in esophageal carcinoma.
Wang F; Xuan XY; Yang X; Cao L; Pang LN; Zhou R; Fan QX; Wang LX
Asian Pac J Cancer Prev; 2014; 15(8):3613-8. PubMed ID: 24870766
[TBL] [Abstract][Full Text] [Related]
2. [Expression of stathmin in esophageal squamous cell carcinoma and its biological significance].
Wang F; Wang LX; He W; Zhu LN; Zhao PR; Fan QX
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jul; 30(7):1552-7. PubMed ID: 20650764
[TBL] [Abstract][Full Text] [Related]
3. Expression of stathmin/op18 as a significant prognostic factor for cervical carcinoma patients.
Xi W; Rui W; Fang L; Ke D; Ping G; Hui-Zhong Z
J Cancer Res Clin Oncol; 2009 Jun; 135(6):837-46. PubMed ID: 19034510
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma.
He Z; Yi J; Jin L; Pan B; Chen L; Song H
Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958
[TBL] [Abstract][Full Text] [Related]
5. High expression of stathmin 1 is a strong prognostic marker in oral squamous cell carcinoma patients treated by docetaxel-containing regimens.
Harada K; Ferdous T; Harada T; Ueyama Y
Clin Exp Med; 2017 Feb; 17(1):45-50. PubMed ID: 26590596
[TBL] [Abstract][Full Text] [Related]
6. Vav1 expression is increased in esophageal squamous cell carcinoma and indicates poor prognosis.
Zhu X; Jin H; Xia Z; Wu X; Yang M; Zhang H; Shang X; Cheng R; Zhan Z; Yu Z
Biochem Biophys Res Commun; 2017 Apr; 486(2):571-576. PubMed ID: 28336434
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Stathmin 1 correlates with poor prognosis and promotes cell migration and proliferation in oesophageal squamous cell carcinoma.
Ni PZ; He JZ; Wu ZY; Ji X; Chen LQ; Xu XE; Liao LD; Wu JY; Li EM; Xu LY
Oncol Rep; 2017 Dec; 38(6):3608-3618. PubMed ID: 29039594
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of melanoma-associated antigen D4 is an independent prognostic factor in squamous cell carcinoma of the esophagus.
Oya H; Kanda M; Takami H; Hibino S; Shimizu D; Niwa Y; Koike M; Nomoto S; Yamada S; Nishikawa Y; Asai M; Fujii T; Nakayama G; Sugimoto H; Fujiwara M; Kodera Y
Dis Esophagus; 2015; 28(2):188-95. PubMed ID: 24147998
[TBL] [Abstract][Full Text] [Related]
9. STMN1, a prognostic predictor of esophageal squamous cell carcinoma, is a marker of the activation of the PI3K pathway.
Jiang W; Huang S; Song L; Wang Z
Oncol Rep; 2018 Feb; 39(2):834-842. PubMed ID: 29251330
[TBL] [Abstract][Full Text] [Related]
10. Stathmin overexpression identifies high risk for lymphatic metastatic recurrence in pN0 esophageal squamous cell carcinoma patients.
Akhtar J; Wang Z; Jiang WP; Bi MM; Zhang ZP
J Gastroenterol Hepatol; 2014 May; 29(5):944-50. PubMed ID: 24372619
[TBL] [Abstract][Full Text] [Related]
11. [Expression level and clinical significance of LncRNA HOXA11-AS in esophageal squamous cell carcinoma patients].
Sun XY; Wang XF; Cui YB; Cao XG; Zhao RH; Wei HY; Cao W; Wu W
Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):186-190. PubMed ID: 29575836
[No Abstract] [Full Text] [Related]
12. Expression and clinical significance of REPS2 in human esophageal squamous cell carcinoma.
Zhang H; Duan CJ; Zhang H; Cheng YD; Zhang CF
Asian Pac J Cancer Prev; 2013; 14(5):2851-7. PubMed ID: 23803043
[TBL] [Abstract][Full Text] [Related]
13. [Clinicopathological and prognostic significance of the expression of ADAM17 mRNA and protein in esophageal squamous cell carcinoma].
Liu HB; Yang QC; Shen Y; Zhu Y; Zhang XJ; Chen H
Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):361-5. PubMed ID: 24054013
[TBL] [Abstract][Full Text] [Related]
14. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
[TBL] [Abstract][Full Text] [Related]
15. Expression of Stathmin and vascular endothelial growth factor C in esophageal cancer and their combined diagnostic value.
Luo X; Dai Y; Cao Y
J BUON; 2019; 24(6):2523-2530. PubMed ID: 31983128
[TBL] [Abstract][Full Text] [Related]
16. [Expression and clinical significance of PI3K in esophageal squamous cell carcinoma].
Zhang Y; Liu YP; Du K; Wang H; Wang XL
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):594-8. PubMed ID: 22325219
[TBL] [Abstract][Full Text] [Related]
17. microRNA-195-Cdc42 axis acts as a prognostic factor of esophageal squamous cell carcinoma.
Sun N; Ye L; Chang T; Li X; Li X
Int J Clin Exp Pathol; 2014; 7(10):6871-9. PubMed ID: 25400770
[TBL] [Abstract][Full Text] [Related]
18. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase D1 mRNA level may predict cancer-specific survival in heavy smokers with esophageal squamous cell cancers.
Xie X; Zhang SS; Wen J; Yang H; Luo KJ; Yang F; Hu Y; Fu JH
Dis Esophagus; 2014; 27(2):188-95. PubMed ID: 23621299
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
Wei R; Shang Z; Leng J; Cui L
J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
